105 related articles for article (PubMed ID: 6491874)
1. [Influence of Corynebacterium parvum, BCG, OK-432 and Lactobacillus casei on the hepatic drug-metabolizing systems and on the oxygen radical production by fixed macrophages in liver of BALB/c mouse].
Hashimoto S; Yokokura T; Mutai M
Yakugaku Zasshi; 1984 Apr; 104(4):356-61. PubMed ID: 6491874
[No Abstract] [Full Text] [Related]
2. The protective activity of immunostimulants against Listeria monocytogenes infection in mice.
Tomioka H; Sato K; Saito H
J Med Microbiol; 1992 Feb; 36(2):112-6. PubMed ID: 1740781
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum.
Hashimoto S; Seyama Y; Yokokura T; Mutai M
Cancer Immunol Immunother; 1985; 20(2):117-21. PubMed ID: 3930066
[TBL] [Abstract][Full Text] [Related]
4. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
Wolmark N; Levine M; Fisher B
J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
[No Abstract] [Full Text] [Related]
5. [Effect of immunopotentiating agents (BCG, picibanil, and levamisole) and Maruyama vaccine on neutrophil functions including the generation of oxygen intermediates].
Niwa Y; Maeda M
Arerugi; 1983 Feb; 32(2):61-71. PubMed ID: 6615239
[No Abstract] [Full Text] [Related]
6. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
7. Protection by BCG, levamisole, PS-K, OK-432, and vitamin E against carbon tetrachloride hepatotoxicity.
Yoshikawa T; Furukawa Y; Wakamatsu Y; Kondo M
Hepatogastroenterology; 1982 Dec; 29(6):240-2. PubMed ID: 7152457
[TBL] [Abstract][Full Text] [Related]
8. Activation of the complement by immunostimulants, BCG, OK-432 (Picibanil), and PS-K (Krestin) in vitro.
Kondo M; Kato H; Yokoe N; Matsumura N; Hotta T; Masuda M
Gan; 1978 Oct; 69(5):699-702. PubMed ID: 729967
[No Abstract] [Full Text] [Related]
9. [Comparative studies of the immunostimulating (paramunizing) effectiveness of BCG, levamisole, Corynebacterium parvum and preparations of pock viruses in various in vivo and in vitro tests].
Mayr A; Büttner M; Pawlas S; Erfle V; Mayr B; Brunner R; Osterkorn K
Zentralbl Veterinarmed B; 1986 Jun; 33(5):321-39. PubMed ID: 2430381
[No Abstract] [Full Text] [Related]
10. Depression of hepatic biotransformations by chemical immunoadjuvants.
Giampietri A; Puccetti P; Contessa AR
J Immunopharmacol; 1981; 3(2):251-64. PubMed ID: 7338632
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between enhancement of natural killer (NK) activity by an immunopotentiator (OK-432) and resistance to human hepatoma cell implantation in nude mice].
Saito H; Morizane T; Kumagai N; Inagaki Y; Nakamura T; Satoh I; Iino A; Matsumura S; Kawamura N; Tsuchiya M
Nihon Shokakibyo Gakkai Zasshi; 1985 Dec; 82(12):2923-9. PubMed ID: 3831444
[No Abstract] [Full Text] [Related]
12. Chemiluminescence in a macrophage cell line modulated by biological response modifiers.
Tosk J; Lau BH; Lui P; Myers RC; Torrey RR
J Leukoc Biol; 1989 Aug; 46(2):103-8. PubMed ID: 2746137
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432.
Kataoka T; Oh-hashi F; Sakurai Y
Cancer Res; 1979 Jul; 39(7 Pt 1):2807-10. PubMed ID: 445486
[TBL] [Abstract][Full Text] [Related]
14. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
15. Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.
Hashimoto S; Nomoto K; Matsuzaki T; Yokokura T; Mutai M
Infect Immun; 1984 Apr; 44(1):61-7. PubMed ID: 6423544
[TBL] [Abstract][Full Text] [Related]
16. [Effects of lipopolysaccharide (E. coli) and OK-432, a Streptococcus preparation, on the hepatic drug-metabolizing system in mice (author's transl)].
Sasaki K; Saitoh M; Takayanagi G
Yakugaku Zasshi; 1981 Oct; 101(10):932-8. PubMed ID: 7040633
[No Abstract] [Full Text] [Related]
17. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
Lichtenstein A; Murahata R; Sugasawara R; Zighelboim J
Cell Immunol; 1981 Mar; 58(2):257-68. PubMed ID: 6452218
[No Abstract] [Full Text] [Related]
18. [Action of Corynebacterium parvum on the activity of glycosidases and proteases of peritoneal macrophages in the mice].
Scharfman A; Houdret N; Roussel P; Biserte G
C R Acad Hebd Seances Acad Sci D; 1978 Sep; 287(4):317-20. PubMed ID: 102445
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
Keller R
J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
Sakita M; Kageyama N; Majima S
Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
